Crea il mio profilo
Accesso pubblico
Visualizza tutto83 articoli
10 articoli
Disponibili
Non disponibili
In base ai mandati di finanziamento
Coautori
- Nitash P. BalsaraUniversity of California, Berkeley, and Lawrence Berkeley National LaboratoryEmail verificata su berkeley.edu
- Kent KirshenbaumProfessor of Chemistry, New York UniversityEmail verificata su nyu.edu
- Rachel SegalmanEdward Noble Kramer Professor of Materials, UCSBEmail verificata su ucsb.edu
- Ken A. DillDirector of Laufer Center, Stony Brook UniversityEmail verificata su laufercenter.org
- F E CohenUCSFEmail verificata su pacbell.net
- Walter H MoosUCSF, Pandect Bioventures, ShangPharma Innovation, SRI, MitoKor, Chiron, Warner-Lambert/Parke-DavisEmail verificata su ucsf.edu
- Sunting XuanSoochow UniversityEmail verificata su suda.edu.cn
- Xi JiangLawrence Berkeley National LaboratoryEmail verificata su lbl.gov
- Eric J. MartinNovartisEmail verificata su novartis.com
- Ryan K SpencerProtomer Technologies, a wholly-owned subsidiary of Eli Lilly and companyEmail verificata su uci.edu
- Stephen WhitelamStaff Scientist, Lawrence Berkeley National LabEmail verificata su lbl.gov
- David PrendergastMolecular Foundry, Lawrence Berkeley National LaboratoryEmail verificata su lbl.gov
- Caroline ProulxNorth Carolina State UniversityEmail verificata su ncsu.edu
- Helen TranUniversity of TorontoEmail verificata su utoronto.ca
- Babak SaniiNutcracker TherapeuticsEmail verificata su nutcrackerx.com
- Glenn ButterfossProteinQureEmail verificata su proteinqure.com
- Adrianne RosalesAssistant Professor, University of Texas at AustinEmail verificata su che.utexas.edu
- Ranjan MannigeCerevel TherapeuticsEmail verificata su lbl.gov
- Ki Tae NamProfessor, Department of Materials Science and Engineering, Seoul National UniversityEmail verificata su snu.ac.kr
- Deborah CharychNektar TherapeuticsEmail verificata su nektar.com
Segui
Ronald N. Zuckermann
Molecular Foundry, Lawrence Berkeley National Laboratory
Email verificata su lbl.gov - Home page